Startseite UR

Publikationen von Hau, Peter

Eine Stufe nach oben
Exportieren als
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Gruppieren nach: Datum | Dokumentenart | Keine Gruppierung
Anzahl der Einträge: 128.

Ippen, Franziska Maria , Scherm, Angelika, Kessler, Tobias, Hau, Peter , Baurecht, Hansjörg , Wick, Wolfgang, Knüttel, Helge , Leitzmann, Michael F. und Seliger, Corinna (2023) Targeted agents in patients with recurrent glioblastoma– a systematic meta-analysis of randomized clinical trials. Neuro-Oncology 25 (Supp.5), v116.

Weidner, Lorraine, Lorenz, Julia, Quach, Stefanie, Braun, Frank K., Rothhammer-Hampl, Tanja, Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Bartos, Laura M., Dekorsy, Franziska J., Holzgreve, Adrien, Kirchleitner, Sabrina V., Thon, Niklas, Greve, Tobias, Ruf, Viktoria, Herms, Jochen, Bader, Stefanie, Milenkovic, Vladimir M., von Baumgarten, Louisa, Menevse, Ayse N., Hussein, Abir, Sax, Julian, Wetzel, Christian H., Rupprecht, Rainer, Proescholdt, Martin A., Schmidt, Nils O., Beckhove, Philipp, Hau, Peter, Tonn, Joerg-Christian, Bartenstein, Peter, Brendel, Matthias, Albert, Nathalie L. und Riemenschneider, Markus J. (2023) Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages. Acta Neuropathologica Communications 11 (1).

Neumann, Bernhard , Onken, Julia, König, Nicole, Stetefeld, Henning, Luger, Sebastian, Luger, Anna-Luisa, Schlachetzki, Felix , Linker, Ralf A. , Hau, Peter und Bumes, Elisabeth (2023) Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis. Journal of Neuro-Oncology.

Braun, Frank K., Rothhammer-Hampl, Tanja , Lorenz, Julia, Pohl, Sandra, Menevse, Ayse-Nur, Vollmann-Zwerenz, Arabel, Bumes, Elisabeth , Büttner, Maren, Zoubaa, Saida, Proescholdt, Martin , Schmidt, Nils O., Hau, Peter , Beckhove, Philipp , Winner, Beate und Riemenschneider, Markus J. (2023) Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype. Cells 12 (14), S. 1856.

Menevse, Ayse N., Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Kupczyk, Marcell, Lorenz, Julia, Weidner, Lorraine, Hussein, Abir, Sax, Julian, Mühlbauer, Jasmin, Heuschneider, Nicole, Rohrmus, Celine, Mai, Laura S., Jachnik, Birgitt, Stamova, Slava, Volpin, Valentina, Durst, Franziska C., Sorrentino, Antonio, Xydia, Maria, Milenkovic, Vladimir M., Bader, Stefanie, Braun, Frank K., Wetzel, Christian H., Albert, Nathalie L., Tonn, Joerg-Christian, Bartenstein, Peter, Proescholdt, Martin, Schmidt, Nils O., Linker, Ralf A., Riemenschneider, Markus J., Beckhove, Philipp und Hau, Peter (2023) TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma. Acta Neuropathologica Communications 11 (1).

Fischl, AnnA, Gerken, Michael, Roos, PhilipP, Haedenkamp, Tareq M. , Hillberg, Andrea, Klinkhammer-Schalke, Monika, Kölbl, Oliver, Linker, Ralf A. , Proescholdt, Martin A. , Pukrop, Tobias , Riemenschneider, Markus J. , Schmidt, Nils Ole , Schön, Ingrid, Vogelhuber, Martin, Hau, Peter und Bumes, Elisabeth (2023) Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study. Neuro-Oncology Practice 10 (5), S. 446-453.

Seliger, Corinna, Rauer, Lisa, Wüster, Anne-Louise, Moeckel, Sylvia, Leidgens, Verena, Jachnik, Birgit, Ammer, Laura-Marie, Heckscher, Simon, Dettmer, Katja , Riemenschneider, Markus J. , Oefner, Peter J. , Proescholdt, Martin A. , Vollmann-Zwerenz, Arabel und Hau, Peter (2023) Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells. International journal of molecular sciences 24 (4).

Scherm, Angelika, Ippen, Franziska Maria , Hau, Peter, Baurecht, Hansjörg , Wick, Wolfgang, Gempt, Jens , Knüttel, Helge , Leitzmann, Michael und Seliger, Corinna (2023) Targeted therapies in patients with newly diagnosed glioblastoma - a systematic meta-analysis of randomized clinical trials. International journal of cancer, (early view).

Scheiter, Alexander , Hierl, Frederik, Lüke, Florian , Keil, Felix , Heudobler, Daniel , Einhell, Sabine, Klier-Richter, Margit, Konstandin, Nikola P., Weber, Florian , Scheiter, Andrea, Kandulski, Arne, Schlosser, Sophie , Cosma, Lidia-Sabina, Tews, Hauke, Weiss, Andreas R. R. , Grube, Matthias, Bumes, Elisabeth , Hau, Peter , Proescholdt, Martin A. , Steger, Felix, Troeger, Anja, Haferkamp, Sebastian , Reibenspies, Lucas E., Schnabel, Marco J., Schulz, Christian , Drexler, Konstantin, Hatzipanagiotou, Maria E., Seitz, Stephan, Klinkhammer-Schalke, Monika, Unberath, Philipp, Calvisi, Diego F. , Pukrop, Tobias , Dietmaier, Wolfgang, Evert, Matthias und Utpatel, Kirsten (2022) Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre. British Journal of Cancer.

Seliger, Corinna, Meyer, Anne-Louise, Leidgens, Verena, Rauer, Lisa, Moeckel, Sylvia, Jachnik, Birgitt, Proske, Judith, Dettmer, Katja, Rothhammer-Hampl, Tanja, Kaulen, Leon D., Riemenschneider, Markus J., Oefner, Peter J., Kreutz, Marina , Schmidt, Nils-Ole, Merrill, Marsha, Uhl, Martin, Renner, Kathrin, Vollmann-Zwerenz, Arabel, Proescholdt, Martin A. und Hau, Peter (2022) Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin. International Journal of Molecular Sciences 23 (19), S. 11629. Volltext nicht vorhanden.

Haedenkamp, Tareq M. , Leitzmann, Michael F. , Linker, Ralf A. , Meier, Christoph, Becker, Claudia, Jick, Susan, Hau, Peter und Seliger, Corinna (2022) Antimicrobial drug use and the risk of glioma: A case–control study. Cancer Medicine, (early view).

Bumes, Elisabeth , Fellner, Claudia, Fellner, Franz A., Fleischanderl, Karin, Häckl, Martina, Lenz, Stefan, Linker, Ralf A. , Mirus, Tim, Oefner, Peter J. , Paar, Christian, Proescholdt, Martin A. , Riemenschneider, Markus J. , Rosengarth, Katharina, Weis, Serge, Wendl, Christina, Wimmer, Sibylle, Hau, Peter , Gronwald, Wolfram und Hutterer, Markus (2022) Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning. Cancers 14 (11), S. 2762.

Ramírez, Eder , Jara, Nery, Ferrada, Luciano, Salazar, Katterine, Martínez, Fernando, Oviedo, María José, Tereszczuk, Joanna, Ramírez-Carbonell, Sebastián, Vollmann-Zwerenz, Arabel, Hau, Peter und Nualart, Francisco (2022) Glioblastoma Invasiveness and Collagen Secretion Are Enhanced by Vitamin C. Antioxidants & Redox Signaling 37 (7-9), S. 538-559. Volltext nicht vorhanden.

Chen, Na, Alieva, Maria , van der Most, Tom, Klazen, Joelle A. Z., Vollmann-Zwerenz, Arabel, Hau, Peter und Vrisekoop, Nienke (2022) Neutrophils Promote Glioblastoma Tumor Cell Migration after Biopsy. Cells 11 (14), S. 2196. Volltext nicht vorhanden.

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael , Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Güresir, Erdem, Schmid, Matthias , Schuss, Patrick , Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank , Herrlinger, Ulrich und Schneider, Matthias (2022) Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial. Trials 23 (1). Volltext nicht vorhanden.

Weller, Johannes , Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael , Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich und Schneider, Matthias (2022) Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. Journal of Neuro-Oncology 159 (1), S. 95-101. Volltext nicht vorhanden.

Dufner, Vera, Kessler, Almuth Friederike, Just, Larissa, Hau, Peter, Bumes, Elisabeth, Pels, Hendrik Johannes, Grauer, Oliver Martin, Wiese, Bettina, Löhr, Mario, Jordan, Karin und Strik, Herwig (2022) The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting. Frontiers in Neurology 13. Volltext nicht vorhanden.

Siska, Peter J., Decking, Sonja-Maria, Babl, Nathalie, Matos, Carina, Bruss, Christina, Singer, Katrin, Klitzke, Jana, Schön, Marian, Simeth, Jakob , Köstler, Josef, Siegmund, Heiko, Ugele, Ines, Paulus, Michael, Dietl, Alexander, Kolodova, Kristina, Steines, Louisa , Freitag, Katharina, Peuker, Alice, Schönhammer, Gabriele, Raithel, Johanna, Graf, Bernhard, Geismann, Florian, Lubnow, Matthias, Mack, Matthias, Hau, Peter, Bohr, Christopher, Burkhardt, Ralph , Gessner, Andre, Salzberger, Bernd, Wagner, Ralf, Hanses, Frank, Hitzenbichler, Florian, Heudobler, Daniel, Lüke, Florian, Pukrop, Tobias, Herr, Wolfgang, Wolff, Daniel, Spang, Rainer, Poeck, Hendrik, Hoffmann, Petra, Jantsch, Jonathan, Brochhausen, Christoph, Lunz, Dirk, Rehli, Michael, Kreutz, Marina und Renner, Kathrin (2021) Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. Journal of Clinical Investigation 131 (22), e148225. Zugang zum Volltext eingeschränkt.

Hau, Peter , Frappaz, Didier, Hovey, Elizabeth, McCabe, Martin G. , Pajtler, Kristian W., Wiestler, Benedikt , Seidel, Clemens, Combs, Stephanie E., Dirven, Linda, Klein, Martin, Anazodo, Antoinette , Hattingen, Elke , Hofer, Silvia, Pfister, Stefan M. , Zimmer, Claus, Kortmann, Rolf-Dieter, Sunyach, Marie-Pierre, Tanguy, Ronan, Effeney, Rachel, von Deimling, Andreas , Sahm, Felix , Rutkowski, Stefan, Berghoff, Anna S., Franceschi, Enrico, Pineda, Estela, Beier, Dagmar , Peeters, Ellen, Gorlia, Thierry, Vanlancker, Maureen, Bromberg, Jacoline E. C., Gautier, Julien, Ziegler, David S. , Preusser, Matthias, Wick, Wolfgang und Weller, Michael (2021) Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23. Cancers 13 (14), S. 3451.

Oefner, Peter J. , Dettmer, Katja, Berger, Raffaela Sarah, Wachsmuth, Christian J., Waldhier, Magdalena C., Renner-Sattler, Kathrin, Thomas, Simone, Chaturvedi, Anuhar , Niller, Hans Helmut , Bumes, Elisabeth, Hau, Peter , Proescholdt, Martin A., Gronwald, Wolfram, Heuser, Michael und Kreutz, Marina (2021) Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite. Cancers 2021 (13), S. 1756.

Tzaridis, Theophilos , Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich und Felsberg, Jörg (2021) MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial. International Journal of Cancer 148 (7), S. 1695-1707. Volltext nicht vorhanden.

van den Bent, Martin J, Tesileanu, C Mircea S , Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M, Erridge, Sarah, Vogelbaum, Michael A, Nowak, Anna K , Baurain, Jean Français, Mason, Warren P, Wheeler, Helen, Chinot, Olivier L, Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter , Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H, Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B, Dubbink, Hendrikus Jan, Kros, Johan M, Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim und Baumert, Brigitta G (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. The Lancet Oncology 22 (6), S. 813-823. Volltext nicht vorhanden.

Nour, Youness, Pöttgen, Christoph, Kebir, Sied , Lazaridis, Lazaros, Lüdemann, Lutz, Guberina, Maja , Gauler, Thomas, Scheffler, Björn, Jabbarli, Ramazan, Pierscianek, Daniela, Sure, Ulrich, Schmidt, Teresa, Oster, Christoph, Hau, Peter, Glas, Martin, Lübcke, Wolfgang, Stuschke, Martin und Guberina, Nika (2021) Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial. Journal of Applied Clinical Medical Physics 22 (1), S. 242-250. Volltext nicht vorhanden.

Goschzik, Tobias, zur Muehlen, Anja, Doerner, Evelyn, Waha, Andreas, Friedrich, Carsten, Hau, Peter und Pietsch, Torsten (2021) Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups. Journal of Neuropathology & Experimental Neurology 80 (5), S. 419-430. Volltext nicht vorhanden.

Seidel, Clemens, Heider, Sina, Hau, Peter , Glasow, Annegret, Dietzsch, Stefan und Kortmann, Rolf-Dieter (2021) Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives. Cancers 13 (23), S. 5945. Volltext nicht vorhanden.

de Castilhos, Juliana , Zamir, Eli, Hippchen, Theresa, Rohrbach, Roman , Schmidt, Sabine, Hengler, Silvana, Schumacher, Hanna , Neubauer, Melanie, Kunz, Sabrina, Müller-Esch, Tonia, Hiergeist, Andreas, Gessner, André, Khalid, Dina, Gaiser, Rogier, Cullin, Nyssa, Papagiannarou, Stamatia M, Beuthien-Baumann, Bettina, Krämer, Alwin, Bartenschlager, Ralf, Jäger, Dirk, Müller, Michael, Herth, Felix, Duerschmied, Daniel , Schneider, Jochen, Schmid, Roland M, Eberhardt, Johann F, Khodamoradi, Yascha , Vehreschild, Maria J G T, Teufel, Andreas, Ebert, Matthias P, Hau, Peter, Salzberger, Bernd, Schnitzler, Paul, Poeck, Hendrik, Elinav, Eran, Merle, Uta und Stein-Thoeringer, Christoph K (2021) Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients. Clinical Infectious Diseases 75 (1), e1063-e1071. Volltext nicht vorhanden.

Bumes, Elisabeth , Wirtz, Fro-Philip, Fellner, Claudia, Grosse, Jirka, Hellwig, Dirk , Oefner, Peter J., Häckl, Martina, Linker, Ralf A., Proescholdt, Martin A., Schmidt, Nils Ole , Riemenschneider, Markus J., Samol, Claudia, Rosengarth, Katharina, Wendl, Christina M., Hau, Peter, Gronwald, Wolfram und Hutterer, Markus (2020) Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning. Cancers 12 (11), S. 3406.

Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Ruf, Viktoria, Wetzel, Christian H. , Riemenschneider, Markus J., Albert, Nathalie L., Beckhove, Philipp und Hau, Peter (2020) The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma. Cancers 12 (10), S. 2973.

Reinert, Christiane, Gerken, Michael, Rathberger, Katharina, Krueger, Katharina, Klinkhammer-Schalke, Monika, Lindberg-Scharf, Patricia, Koelbl, Oliver, Proescholdt, Martin A. , Riemenschneider, Markus J., Pukrop, Tobias , Bumes, Elisabeth , Hutterer, Markus und Hau, Peter (2020) Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers. BMC Psychology 8, S. 96.

Lorenz, Julia, Rothhammer-Hampl, Tanja, Zoubaa, Saida, Bumes, Elisabeth, Pukrop, Tobias, Kölbl, Oliver, Corbacioglu, Selim, Schmidt, Nils O. , Proescholdt, Martin A., Hau, Peter und Riemenschneider, Markus J. (2020) A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology. Acta Neuropathologica Communications 8, S. 124.

Hau, Peter, Dirven, Linda, Luerding, Ralf, Beier, Dagmar, Bumes, Elisabeth, Reinert, Christiane, Seidel, Clemens, Bonsanto, Matteo Mario, Bremer, Michael, Rieken, Stefan, Combs, Stephanie E., Herrlinger, Ulrich, Seliger, Corinna, Kuntze, Holger, Mayer‑Steinacker, Regine, Dieing, Annette, Bartels, Claudius, Schnell, Oliver, Weyerbrock, Astrid, Seidel, Sabine, Grauer, Oliver, Nadji‑Ohl, Minou, Paulsen, Frank , Weller, Michael und Wick, Wolfgang (2020) Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. Journal of Neuro-Oncology 148, S. 117-130.

Franceschi, Enrico, Frappaz, Didier, Rudà, Roberta, Hau, Peter, Preusser, Matthias, Houillier, Caroline, Lombardi, Giuseppe, Asioli, Sofia , Dehais, Caroline, Bielle, Franck, Di Nunno, Vincenzo, van den Bent, Martin, Brandes, Alba A. und Idbaih, Ahmed (2020) Rare Primary Central Nervous System Tumors in Adults: An Overview. Frontiers in Oncology 10. Volltext nicht vorhanden.

Vollmann-Zwerenz, Arabel, Leidgens, Verena, Feliciello, Giancarlo, Klein, Christoph A. und Hau, Peter (2020) Tumor Cell Invasion in Glioblastoma. International Journal of Molecular Sciences 21 (6), S. 1932. Volltext nicht vorhanden.

Seliger, Corinna, Genbrugge, Els, Gorlia, Thierry, Chinot, Olivier, Stupp, Roger, Nabors, Burt, Weller, Michael und Hau, Peter (2020) Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis. International Journal of Cancer 146 (3), S. 803-809. Volltext nicht vorhanden.

Anssar, Tareq M., Leitzmann, Michael F., Linker, Ralf A., Meier, Christoph, Becker, Claudia, Jick, Susan, Sahm, Katharina, Platten, Michael , Hau, Peter und Seliger, Corinna (2019) Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma. Cancer Medicine 9 (3), S. 1263-1275.

Alieva, Maria, Leidgens, Verena, Riemenschneider, Markus J., Klein, Christoph A., Hau, Peter und van Rheenen, Jacco (2019) Intravital imaging of glioma border morphology reveals distinctive cellular dynamics and contribution to tumor cell invasion. Scientific Reports 9 (2054), S. 1-11.

Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert , Weller, Johannes , Mack, Frederic, Tzaridis, Theophilos, Bähr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh , Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin und Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. Journal of Neuro-Oncology 144 (3), S. 501-509. Volltext nicht vorhanden.

Hoffmann, Johannes, Hau, Peter, Pukrop, Tobias und Karthaus, Meinolf (2019) Gliome und ihre medikamentöse Behandlung. Der Onkologe 25 (1), S. 53-59. Volltext nicht vorhanden.

Weller, Johannes , Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert , Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich und Schäfer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology 20 (10), S. 1444-1453. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.

Seliger, Corinna, Schaertl, Julia, Gerken, Michael, Luber, Christian, Proescholdt, Martin, Riemenschneider, Markus J., Leitzmann, Michael F., Hau, Peter und Klinkhammer-Schalke, Monika (2018) Use of statins or NSAIDs and survival of patients with high-grade glioma. PLOS ONE 13 (12), e0207858.

Seliger, Corinna und Hau, Peter (2018) Drug Repurposing of Metabolic Agents in Malignant Glioma. International Journal of Molecular Sciences 19 (9), S. 2768.

Gerthofer, V., Kreutz, Marina, Renner, Kathrin, Jachnik, Birgit, Dettmer, Katja, Oefner, Peter J., Riemenschneider, Markus J., Proescholdt, Martin A., Vollmann-Zwerenz, Arabel, Hau, Peter und Seliger, Corinna (2018) Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma. Int J Mol Sci 19 (9).

Reinert, Christiane , Rathberger, Katharina, Klinkhammer-Schalke, Monika, Kölbl, Oliver, Proescholdt, Martin, Riemenschneider, Markus J., Schuierer, Gerhard, Hutterer, Markus, Gerken, Michael und Hau, Peter (2018) Information needs and requirements in patients with brain tumours and their relatives. Journal of Neuro-Oncology 138 (2), S. 407-415. Volltext nicht vorhanden.

Beier, Dagmar, Kocakaya, Selin, Hau, Peter und Beier, Christoph Patrick (2018) The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ. Clinical Neuroradiology 28 (1), S. 99-107. Volltext nicht vorhanden.

Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke , Schäfer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid, Hau, Peter , Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Bähr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Hänel, Mathias, Sabel, Michael, Gerlach, Rüdiger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich und Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589. Volltext nicht vorhanden.

Seliger, Corinna, Luber, Christian, Gerken, Michael, Schaertl, Julia, Proescholdt, Martin, Riemenschneider, Markus J., Meier, Christoph R., Bogdahn, Ulrich, Leitzmann, Michael F., Klinkhammer-Schalke, Monika und Hau, Peter (2018) Use of metformin and survival of patients with high-grade glioma. International Journal of Cancer 144 (2), S. 273-280. Volltext nicht vorhanden.

Haj, Amer, Doenitz, Christian, Schebesch, Karl-Michael, Ehrensberger, Denise, Hau, Peter , Putnik, Kurt, Riemenschneider, Markus, Wendl, Christina, Gerken, Michael, Pukrop, Tobias, Brawanski, Alexander und Proescholdt, Martin (2017) Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sciences 8 (1), S. 5.

Leitzmann, Michael F., Seliger, Corinna, Meier, Christoph R., Becker, Claudia , Jick, Susan S., Proescholdt, Martin, Bogdahn, Ulrich und Hau, Peter (2017) Diabetes, use of metformin, and the risk of meningioma. PLoS ONE 12 (7), e0181089.

Merkel, Andreas, Soeldner, Dorothea, Wendl, Christina, Urkan, Dilek, Kuramatsu, Joji B., Seliger, Corinna, Proescholdt, Martin, Eyupoglu, Ilker Y., Hau, Peter und Uhl, Martin (2017) Early postoperative tumor progression predicts clinical outcome in glioblastoma—implication for clinical trials. Journal of Neuro-Oncology 132 (2), S. 249-254. Volltext nicht vorhanden.

van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang und Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet 390 (10103), S. 1645-1653. Volltext nicht vorhanden.

Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S. , Proescholdt, Martin, Bogdahn, Ulrich, Hau, Peter und Leitzmann, Michael F. (2017) Metabolic syndrome in relation to risk of meningioma. Oncotarget 8 (2). Volltext nicht vorhanden.

Beier, Dagmar, Proescholdt, Martin, Reinert, Christiane, Pietsch, Torsten, Jones, David T W , Pfister, Stefan M , Hattingen, Elke , Seidel, Clemens, Dirven, Linda, Luerding, Ralf, Reijneveld, Jaap, Warmuth-Metz, Monika, Bonsanto, Matteo, Bremer, Michael, Combs, Stephanie E, Rieken, Stefan, Herrlinger, Ulrich, Kuntze, Holger, Mayer-Steinacker, Regine, Moskopp, Dag, Schneider, Thomas, Beringer, Andreas, Schlegel, Uwe, Stummer, Walter, Welker, Helmut, Weyerbrock, Astrid, Paulsen, Frank, Rutkowski, Stefan, Weller, Michael, Wick, Wolfgang, Kortmann, Rolf-Dieter, Bogdahn, Ulrich und Hau, Peter (2017) Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro-Oncology 20 (3), S. 400-410. Volltext nicht vorhanden.

de Balincourt, Christine, Lacombe, Denis , Coens, Corneel, den Dulk, Marcel, Machiels, Jean-Pascal, Weber, Damien, Spahn, Martin, Salgado, Roberto, Kasper, Bernd, Hau, Peter, Licitra, Lisa, Betsou, Fay, Kataoka, Kozo, Caballero, Carmela, Liu, Yan, Hurkmans, Coen und Evrard, Serge (2017) Multidisciplinary quality assurance and control in oncological trials: Perspectives from European Organisation for Research and Treatment of Cancer (EORTC). European Journal of Cancer 86, S. 91-100. Volltext nicht vorhanden.

Schäfer, Niklas, Proescholdt, Martin, Steinbach, Joachim P, Weyerbrock, Astrid, Hau, Peter , Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W, Uhl, Martin, Grau, Stefan, Hänel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos, Nießen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin und Herrlinger, Ulrich (2017) Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology 20 (7), S. 975-985. Volltext nicht vorhanden.

Leidgens, Verena, Proske, Judith, Rauer, Lisa, Moeckel, Sylvia, Renner, Kathrin, Bogdahn, Ulrich, Riemenschneider, Markus J., Proescholdt, Martin, Vollmann-Zwerenz, Arabel, Hau, Peter und Seliger, Corinna (2017) Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. Oncotarget 8 (5). Volltext nicht vorhanden.

Riemenschneider, Markus J., Hoja, Sabine, Schulze, Markus, Rehli, Michael, Proescholdt, Martin A., Herold-Mende, Christel und Hau, Peter (2016) Molecular dissection of the valproic acid effects on glioma cells. Oncotarget 7 (39), S. 62989-63002.

Seliger, Corinna, Meyer, A. L., Renner, K., Leidgens, V., Moeckel, S., Jachnik, B., Dettmer, Katja , Tischler, U., Gerthofer, V., Rauer, L., Uhl, M., Proescholdt, M., Bogdahn, U., Riemenschneider, M. J., Oefner, Peter J., Kreutz, M., Vollmann-Zwerenz, A. und Hau, Peter (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2. Cell Cycle 15 (13), S. 1755-1766. Volltext nicht vorhanden.

Moeckel, Sylvia, Vollmann-Zwerenz, Arabel, Proescholdt, Martin A., Brawanski, Alexander, Riemenschneider, Markus J., Bogdahn, Ulrich, Bosserhoff, A. K. , Spang, Rainer und Hau, Peter (2016) Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro. PLoS ONE 11 (3), e0151312.

Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S. , Bogdahn, Ulrich, Hau, Peter und Leitzmann, Michael F. (2016) Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma. PLoS ONE 11 (2), e0149293.

Bumes, Elisabeth, Rzonsa, Sarah, Hutterer, Markus, Proescholdt, Martin, Bogdahn, Ulrich, Riemenschneider, Markus J., Uhl, Martin, Wendl, Christina und Hau, Peter (2016) Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab. Journal of Neuro-Oncology 127 (1), S. 191-200. Volltext nicht vorhanden.

Herrlinger, Ulrich, Schäfer, Niklas, Steinbach, Joachim P. , Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W. , Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Hänel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Rüdiger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tüttenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter und Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. Journal of Clinical Oncology 34 (14), S. 1611-1619. Volltext nicht vorhanden.

Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian , Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. und Wirsching, Hans-Georg (2016) Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial. Neuro-Oncology 18 (4), S. 549-556. Volltext nicht vorhanden.

Hutterer, Markus , Ebner, Yvonne, Riemenschneider, Markus J., Willuweit, Antje , McCoy, Mark, Egger, Barbara, Schröder, Michael, Wendl, Christina, Hellwig, Dirk, Grosse, Jirka, Menhart, Karin, Proescholdt, Martin, Fritsch, Brita, Urbach, Horst, Stockhammer, Guenther, Roelcke, Ulrich, Galldiks, Norbert , Meyer, Philipp T., Langen, Karl-Josef , Hau, Peter und Trinka, Eugen (2016) Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18 F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic. Journal of Nuclear Medicine 58 (1), S. 129-137. Volltext nicht vorhanden.

Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Bromberg, Jacoline E. C., Mason, Warren P., Hoang-Xuan, Khê, Ryan, Gail, Hassel, Mohamed Ben, Enting, Roelien H., Brandes, Alba A., Wick, Antje, Chinot, Olivier, Reni, Michele, Kantor, Guy, Thiessen, Brian, Klein, Martin, Verger, Eugenie, Borchers, Christian, Hau, Peter, Back, Michael, Smits, Anja, Golfinopoulos, Vassilis, Gorlia, Thierry, Bottomley, Andrew, Stupp, Roger und Baumert, Brigitta G. (2016) Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology 17 (11), S. 1533-1542. Volltext nicht vorhanden.

Illerhaus, Gerald, Kasenda, Benjamin, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha, Hau, Peter, Edinger, Matthias , Frickhofen, Norbert, Bentz, Martin, Möhle, Robert, Röth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina und Finke, Jürgen (2016) High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. The Lancet Haematology 3 (8), e388-e397. Volltext nicht vorhanden.

Wick, Wolfgang, Roth, Patrick , Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian , Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas , Meisner, Christoph , Wiestler, Benedikt und Weller, Michael (2016) Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-Oncology, now133. Volltext nicht vorhanden.

Gallo-Oller, Gabriel , Vollmann-Zwerenz, Arabel, Meléndez, Bárbara , Rey, Juan A., Hau, Peter, Dotor, Javier und Castresana, Javier S. (2016) P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines. Cancer Letters 381 (1), S. 67-75. Volltext nicht vorhanden.

Schliesser, Maximilian Georg, Claus, Rainer, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter, Schramm, Johannes, Sahm, Felix, Weiß, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick , Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas , Meisner, Christoph, Vajkoczy, Peter, Platten, Michael , Weller, Michael, Plass, Christoph und Wick, Wolfgang (2016) Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget 7 (50). Volltext nicht vorhanden.

Seliger, Corinna, Meier, Christoph Rudolf, Becker, Claudia, Jick, Susan Sara , Bogdahn, Ulrich, Hau, Peter und Leitzmann, Michael Fred (2016) Statin use and risk of glioma: population-based case–control analysis. European Journal of Epidemiology 31 (9), S. 947-952. Volltext nicht vorhanden.

Seliger, Corinna, Meier, Christoph R., Jick, Susan S. , Uhl, Martin, Bogdahn, Ulrich, Hau, Peter und Leitzmann, M. F. (2016) Use of cardiac glycosides and risk of glioma. Journal of Neuro-Oncology 127 (2), S. 321-328. Volltext nicht vorhanden.

Hau, Peter, Leidgens, Verena, Seliger, Corinna, Jachnik, Birgit, Welz, Tobias, Leukel, Petra, Vollmann-Zwerenz, Arabel, Bogdahn, Ulrich, Kreutz, Marina und Grauer, Oliver M. (2015) Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms. PLoS ONE 10 (10), e0140613.

Seliger, Corinna, Ricci, Cristian, Meier, Christoph R., Bodmer, Michael, Jick, Susan S. , Bogdahn, Ulrich, Hau, Peter und Leitzmann, Michael F. (2015) Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro-Oncology 18 (3), S. 340-349. Volltext nicht vorhanden.

Hau, Peter, Moeckel, Sylvia, Meyer, Katharina, Leukel, Petra, Heudorfer, Fabian, Seliger, Corinna, Stangl, Christina, Bogdahn, Ulrich, Proescholdt, Martin A., Brawanski, Alexander, Vollmann-Zwerenz, Arabel, Riemenschneider, Markus J., Bosserhoff, Anja-Katrin und Spang, Rainer (2014) Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro. PLoS ONE 9 (9), e108632.

Reinert, C., Kremmler, L., Burock, S., Bogdahn, Ulrich, Wick, W., Gleiter, C. H., Koller, M. und Hau, Peter (2014) Quantitative and qualitative analysis of study-related patient information sheets in randomized neuro-oncology phase III-trials. European Journal of Cancer. (Im Druck) Volltext nicht vorhanden.

Kreutz, Marina, Gottfried, Eva, Lang, Sven A., Renner, Kathrin, Bosserhoff, Anja-Katrin, Gronwald, Wolfram, Rehli, Michael, Einhell, Sabine, Gedig, Isabel, Singer, Katrin, Seilbeck, Anton, Mackensen, Andreas, Grauer, Oliver, Hau, Peter, Dettmer, Katja, Andreesen, Reinhard und Oefner, Peter (2013) New aspects of an old drug: Diclofenac targets MYC and glucose metabolism in tumor cells. PLoS ONE 8 (7), e66987.

Ramm Sander, Paul, Hau, Peter, Koch, Steffen, Schütze, Karin, Bogdahn, Ulrich, Kalbitzer, Hans Robert und Aigner, Ludwig (2013) Stem cell metabolic and spectroscopic profiling. Trends in biotechnology 31 (3), S. 204-213. Volltext nicht vorhanden.

Chirasani, Sridhar Reddy, Leukel, Petra, Gottfried, Eva, Hochrein, Jochen, Stadler, Katrin, Neumann, Bernhard, Oefner, Peter J., Gronwald, Wolfram, Bogdahn, Ulrich, Hau, Peter, Kreutz, Marina und Grauer, Oliver M. (2013) Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. International Journal of Cancer 132 (4), S. 843-853. Volltext nicht vorhanden.

Uhl, M. und Hau, Peter (2013) High-Grade Glioma: Refined Diagnostics Steering Stratified Therapy. Case reports in oncology 6 (2), S. 387-389.

Seliger, Corinna, Leukel, Petra, Moeckel, Sylvia, Jachnik, Birgit, Lottaz, Claudio, Kreutz, Marina, Brawanski, Alexander, Proescholdt, Martin, Bogdahn, Ulrich, Bosserhoff, Anja-Katrin, Vollmann-Zwerenz, Arabel und Hau, Peter (2013) Lactate-Modulated Induction of THBS-1 Activates Transforming Growth Factor (TGF)-beta2 and Migration of Glioma Cells In Vitro. PloS one 8 (11), e78935.

Uhl, M. und Hau, Peter (2013) Neues aus der Neuroonkologie. Aktuelle Neurologie 40 (4), S. 180-184. Volltext nicht vorhanden.

Hutterer, Markus, Steurer, Michael, Höftberger, Romana, Hainfellner, Johannes A., Pircher, Andreas, Nowosielski, Martha, Hau, Peter, Löscher, Wolfgang, Gunsilius, Eberhard, Berger, Thomas und Stockhammer, Guenther (2013) Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature. Clinical neuropathology. Volltext nicht vorhanden.

Riemenschneider, Markus J., Louis, David N., Weller, Michael und Hau, Peter (2013) Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. Acta neuropathologica 126 (1), S. 21-37. Volltext nicht vorhanden.

Friedrich, Carsten, von Bueren, André O., von Hoff, Katja, Kwiecien, Robert, Pietsch, Torsten, Warmuth-Metz, Monika, Hau, Peter, Deinlein, Frank, Kuehl, Joachim, Kortmann, Rolf D. und Rutkowski, Stefan (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. European journal of cancer 49 (4), S. 893-903. Volltext nicht vorhanden.

Beier, Christoph P., Kumar, Praveen, Meyer, Katharina, Leukel, Petra, Bruttel, Valentin, Aschenbrenner, Ines, Riemenschneider, Markus J., Fragoulis, Athanassios, Rümmele, Petra, Lamszus, Katrin, Schulz, Jörg B., Weis, Joachim, Bogdahn, Ulrich, Wischhusen, Jörg, Hau, Peter, Spang, Rainer und Beier, Dagmar (2012) The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells and Development 21 (15), S. 2753-2761. Volltext nicht vorhanden.

Ramm, Paul, Bettscheider, Marc, Beier, Dagmar, Kalbitzer, Hans Robert, Kremer, Werner, Bogdahn, Ulrich, Hau, Peter, Aigner, Ludwig und Beier, Christoph P. (2011) 1H-nuclear magnetic resonance spectroscopy of glioblastoma cancer stem cells. Stem cells and development 20 (12), S. 2189-2195. Volltext nicht vorhanden.

Stupp, R., Tosoni, A., Bromberg, J. E. C., Hau, Peter, Campone, M., Gijtenbeek, J., Frenay, M., Breimer, L., Wiesinger, H., Allgeier, A., van den Bent, M. J., Bogdahn, Ulrich, van der Graaf, W., Yun, H. J., Gorlia, T., Lacombe, D. und Brandes, A. A. (2011) Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 22 (9), S. 2144-2149. Volltext nicht vorhanden.

Hau, Peter, Jachimczak, Piotr, Schlaier, Jürgen und Bogdahn, Ulrich (2011) TGF-β2 signaling in high-grade gliomas. Current pharmaceutical biotechnology 12 (12), S. 2150-2157. Volltext nicht vorhanden.

Bogdahn, Ulrich, Hau, Peter, Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., Poverennova, I., Zaaroor, M., Jachimczak, P., Ludwig, S., Schmaus, S., Heinrichs, H. und Schlingensiepen, K. H. (2011) Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-oncology 13 (1), S. 132-142. Volltext nicht vorhanden.

Grauer, Oliver, Pascher, Christina, Hartmann, Christian, Zeman, Florian, Weller, Michael, Proescholdt, Martin A., Brawanski, Alexander, Pietsch, Thorsten, Wick, Wolfgang, Bogdahn, Ulrich und Hau, Peter (2011) Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). Journal of neuro-oncology 104 (3), S. 801-809. Volltext nicht vorhanden.

Wismeth, Caecilia, Dudel, Christine, Pascher, Christina, Ramm, Paul, Pietsch, Torsten, Hirschmann, Birgit, Reinert, Christiane, Proescholdt, Martin A., Rümmele, Petra, Schuierer, Gerhard, Bogdahn, Ulrich und Hau, Peter (2010) Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. Journal of neuro-oncology 98 (3), S. 395-405. Volltext nicht vorhanden.

Stupp, Roger, Hegi, Monika E., Mason, Warren P., van den Bent, Martin J., Taphoorn, Martin J. B., Janzer, Robert C., Ludwin, Samuel K., Allgeier, Anouk, Fisher, Barbara, Belanger, Karl, Hau, Peter, Brandes, Alba A., Gijtenbeek, Johanna, Marosi, Christine, Vecht, Charles J., Mokhtari, Karima, Wesseling, Pieter, Villa, Salvador, Eisenhauer, Elizabeth, Gorlia, Thierry, Weller, Michael, Lacombe, Denis, Cairncross, J. Gregory und Mirimanoff, René-Olivier (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The lancet oncology 10 (5), S. 459-466. Volltext nicht vorhanden.

Baumann, Fusun, Leukel, Petra, Doerfelt, Anett, Beier, Christoph P., Dettmer, Katja, Oefner, Peter J., Kastenberger, Michael, Kreutz, Marina, Nickl-Jockschat, Thomas, Bogdahn, Ulrich, Bosserhoff, Anja-Katrin und Hau, Peter (2009) Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro-oncology 11 (4), S. 368-380. Volltext nicht vorhanden.

Reardon, D. A., Dresemann, G., Taillibert, S., Campone, M., van den Bent, M., Clement, P., Blomquist, E., Gordower, L., Schultz, H., Raizer, J., Hau, Peter, Easaw, J., Gil, M., Tonn, J., Gijtenbeek, A., Schlegel, U., Bergstrom, P., Green, S., Weir, A. und Nikolova, Z. (2009) Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. British journal of cancer 101 (12), S. 1995-2004. Volltext nicht vorhanden.

Beier, Christoph P., Schmid, Christina, Gorlia, Thierry, Kleinletzenberger, Christine, Beier, Dagmar, Grauer, Oliver, Steinbrecher, Andreas, Hirschmann, Birgit, Brawanski, Alexander, Dietmaier, Christopher, Jauch-Worley, Tanja, Kölbl, Oliver, Pietsch, Torsten, Proescholdt, Martin A., Rümmele, Petra, Muigg, Armin, Stockhammer, Günther, Hegi, Monika, Bogdahn, Ulrich und Hau, Peter (2009) RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC cancer 9, S. 308.

Wick, Antje, Pascher, Christina, Wick, Wolfgang, Jauch, Tanja, Weller, Michael, Bogdahn, Ulrich und Hau, Peter (2009) Rechallenge with temozolomide in patients with recurrent gliomas. Journal of neurology 256 (5), S. 734-741. Volltext nicht vorhanden.

Hau, Peter, Jachimczak, Piotr und Bogdahn, Ulrich (2009) Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides. Expert review of anticancer therapy 9 (11), S. 1663-1674. Volltext nicht vorhanden.

Beier, Dagmar, Wischhusen, Jörg, Dietmaier, Wolfgang, Hau, Peter, Proescholdt, Martin A., Brawanski, Alexander, Bogdahn, Ulrich und Beier, Christoph P. (2008) CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain pathology 18 (3), S. 370-377. Volltext nicht vorhanden.

Glas, Martin, Hennemann, Burkhard, Hirschmann, Birgit, Marienhagen, Jörg, Schmidt-Wolf, Ingo, Herrlinger, Ulrich, Bogdahn, Ulrich und Hau, Peter (2008) Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma. Acta oncologica 47 (3), S. 479-480. Volltext nicht vorhanden.

Goerne, Rainer, Bogdahn, Ulrich und Hau, Peter (2008) Procarbazine--a traditional drug in the treatment of malignant gliomas. Current medicinal chemistry 15 (14), S. 1376-1387. Volltext nicht vorhanden.

Beier, Dagmar, Röhrl, Stefanie, Pillai, Deepu R., Schwarz, Stefanie, Kunz-Schughart, Leoni A., Leukel, Petra, Proescholdt, Martin A., Brawanski, Alexander, Bogdahn, Ulrich, Trampe-Kieslich, Ariane, Giebel, Bernd, Wischhusen, Jörg, Reifenberger, Guido, Hau, Peter und Beier, Christoph P. (2008) Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer research 68 (14), S. 5706-5715. Volltext nicht vorhanden.

Ickenstein, G. W., Valaikiene, J., Koch, H., Hau, Peter, Erban, P. und Schlachetzki, F. (2008) Ultrasonic contrast agents in transcranial perfusion sonography (TPS) for follow-up of patients with high grade gliomas. Ultrasonics sonochemistry 15 (4), S. 510-516. Volltext nicht vorhanden.

Beier, D., Hau, Peter, Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, Peter J., Aigner, L., Brawanski, Alexander, Bogdahn, Ulrich und Beier, Christoph P. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research 67 (9), S. 4010-4015. Volltext nicht vorhanden.

Nickl-Jockschat, T., Arslan, F., Doerfelt, A., Bogdahn, U., Bosserhoff, A. und Hau, Peter (2007) An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas. International journal of oncology 30 (2), S. 499-507.

Beier, Dagmar, Hau, Peter, Proescholdt, Martin A., Lohmeier, Annette, Wischhusen, Jörg, Oefner, Peter J., Aigner, Ludwig, Brawanski, Alexander, Bogdahn, Ulrich und Beier, Christoph P. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer research 67 (9), S. 4010-4015. Volltext nicht vorhanden.

Hau, Peter, Jachimczak, Piotr, Schlingensiepen, Reimar, Schulmeyer, Frank, Jauch, Tanya, Steinbrecher, Andreas, Brawanski, Alexander, Proescholdt, Martin A., Schlaier, Jürgen, Buchroithner, Johanna, Pichler, Josef, Wurm, Gabriele, Mehdorn, Maximilian, Strege, Rainer, Schuierer, Gerhard, Villarrubia, Victoria, Fellner, Franz, Jansen, Olav, Straube, Thorsten, Nohria, Virinder, Goldbrunner, Michael, Kunst, Mechthild, Schmaus, Susanne, Stauder, Gerhard, Bogdahn, Ulrich und Schlingensiepen, Karl-Hermann (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17 (2), S. 201-212. Volltext nicht vorhanden.

Hau, Peter, Kunz-Schughart, L., Bogdahn, U., Baumgart, U., Hirschmann, B., Weimann, E., Muhleisen, H., Ruemmele, P., Steinbrecher, A. und Reichle, A. (2007) Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study. Oncology 73 (1-2), S. 21-25. Volltext nicht vorhanden.

Hau, Peter, Stupp, Roger und Hegi, Monika E. (2007) MGMT methylation status: the advent of stratified therapy in glioblastoma? Disease markers 23 (1-2), S. 97-104. Volltext nicht vorhanden.

Glas, Martin, Koch, Horst, Hirschmann, Birgit, Jauch, Tanja, Steinbrecher, Andreas, Herrlinger, Ulrich, Bogdahn, Ulrich und Hau, Peter (2007) Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series. Oncology 72 (5-6), S. 302-307. Volltext nicht vorhanden.

Wagner, Sabine, Peters, Ove, Fels, Christin, Janssen, Gisela, Liebeskind, Anne-Kathrin, Sauerbrey, Axel, Suttorp, Meinolf, Hau, Peter und Wolff, Johannes E. A. (2007) Pegylated-liposomal doxorubicin and oral topotecan in eight children with relapsed high-grade malignant brain tumors. Journal of neuro-oncology 86 (2), S. 175-181. Volltext nicht vorhanden.

Hau, Peter, Koch, D., Hundsberger, T., Marg, E., Bauer, B., Rudolph, R., Rauch, M., Brenner, A., Rieckmann, P., Schuth, J., Jauch, T., Koch, H. und Bogdahn, U. (2007) Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 68 (9), S. 688-690. Volltext nicht vorhanden.

Arslan, F., Bosserhoff, A. K. , Nickl-Jockschat, T., Doerfelt, A., Bogdahn, U. und Hau, Peter (2007) The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. British journal of cancer 96 (10), S. 1560-1568. Volltext nicht vorhanden.

Hau, Peter, Kunz-Schughart, Leoni A., Rümmele, Petra, Arslan, Füsun, Dörfelt, Anett, Koch, Horst, Lohmeier, Annette, Hirschmann, Birgit, Müller, Adolf, Bogdahn, Ulrich und Bosserhoff, Anja-Katrin (2006) Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. Journal of neuro-oncology 77 (1), S. 1-7. Zugang zum Volltext eingeschränkt.

Koch, H. J., Klinkhammer-Schalke, M., Hofstädter, F., Bogdahn, U. und Hau, Peter (2006) Seasonal patterns of birth in patients with glioblastoma. Chronobiology international 23 (5), S. 1047-1052. Volltext nicht vorhanden.

Schlingensiepen, Karl-Hermann, Schlingensiepen, Reimar, Steinbrecher, Andreas, Hau, Peter, Bogdahn, Ulrich, Fischer-Blass, Birgit und Jachimczak, Piotr (2006) Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009. Cytokine & growth factor reviews 17 (1-2), S. 129-139. Zugang zum Volltext eingeschränkt.

Herrlinger, Ulrich, Steinbrecher, A., Rieger, J., Hau, Peter, Kortmann, R.-D., Meyermann, R., Schabet, M., Bamberg, M., Dichgans, J., Bogdahn, U. und Weller, M. (2005) Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. Journal of neurology 252 (3), S. 291-299. Volltext nicht vorhanden.

Jachimczak, Piotr, Apfel, Rainer, Bosserhoff, Anja-Katrin, Fabel, Klaus, Hau, Peter, Tschertner, Ines, Wise, Petra, Schlingensiepen, Karl-Hermann, Schuler-Thurner, Beatrix und Bogdahn, Ulrich (2005) Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques. International journal of cancer. Journal international du cancer 113 (1), S. 88-92. Volltext nicht vorhanden.

Schlingensiepen, Reimar, Goldbrunner, Michael, Szyrach, Mara N. I., Stauder, Gerhard, Jachimczak, Piotr, Bogdahn, Ulrich, Schulmeyer, Frank, Hau, Peter und Schlingensiepen, Karl-Hermann (2005) Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides 15 (2), S. 94-104. Volltext nicht vorhanden.

Hegi, Monika E., Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M., Hainfellner, Johannes A., Mason, Warren, Mariani, Luigi, Bromberg, Jacoline E. C., Hau, Peter, Mirimanoff, René O., Cairncross, J. Gregory, Janzer, Robert C. und Stupp, Roger (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England journal of medicine 352 (10), S. 997-1003. Volltext nicht vorhanden.

Hau, Peter, Ruemmele, Petra, Kunz-Schughart, Leoni A., Doerfelt, Anett, Hirschmann, Birgit, Lohmeier, Annette, Koch, Horst, Mueller, Adolf, Bogdahn, Ulrich und Bosserhoff, Anja-Katrin (2004) Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Oncology reports 12 (6), S. 1355-1364. Volltext nicht vorhanden.

Kleiter, I., Hans, V. H., Schuierer, G., Marienhagen, J., Hau, Peter, Schütz, H., Bogdahn, U. und Steinbrecher, A. (2004) Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis. Journal of neurology, neurosurgery, and psychiatry 75 (9), S. 1346-1348. Volltext nicht vorhanden.

Wismeth, Caecilia, Hau, Peter, Fabel, Klaus, Baumgart, Ulrike, Hirschmann, Birgit, Koch, Horst, Jauch, Tanja, Grauer, Oliver, Drechsel, Lisa, Brawanski, Alexander, Bogdahn, Ulrich und Steinbrecher, Andreas (2004) Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study. Journal of neuro-oncology 68 (1), S. 79-86. Volltext nicht vorhanden.

Hau, Peter, Fabel, Klaus, Baumgart, Ulrike, Rümmele, Petra, Grauer, Oliver, Bock, Annekatrin, Dietmaier, Christopher, Dietmaier, Wolfgang, Dietrich, Jörg, Dudel, Christine, Hübner, Franz, Jauch, Tanya, Drechsel, Elisabeth, Kleiter, Ingo, Wismeth, Cäcile, Zellner, Anton, Brawanski, Alexander, Steinbrecher, Andreas, Marienhagen, Jörg und Bogdahn, Ulrich (2004) Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer 100 (6), S. 1199-1207. Volltext nicht vorhanden.

Hau, Peter, Baumgart, Ulrike, Pfeifer, Katharina, Bock, Anne, Jauch, Tanya, Dietrich, Jörg, Fabel, Klaus, Grauer, Oliver, Wismeth, Caecilia, Klinkhammer-Schalke, Monika, Allgäuer, Michael, Schuierer, Gerhard, Koch, Horst, Schlaier, Juergen, Ulrich, Winfried, Brawanski, Alexander, Bogdahn, Ulrich und Steinbrecher, Andreas (2003) Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98 (12), S. 2678-2686. Volltext nicht vorhanden.

Hau, Peter, Dietrich, Joerg, Fabel, Klaus und Bogdahn, Ulrich (2002) Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert review of neurotherapeutics 2 (5), S. 609-615. Volltext nicht vorhanden.

Hau, Peter, Wise, Petra, Bosserhoff, Anja-Katrin, Blesch, Armin, Jachimczak, Piotr, Tschertner, Ines, Bogdahn, Ulrich und Apfel, Rainer (2002) Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected]. The Journal of investigative dermatology 119 (3), S. 562-569. Volltext nicht vorhanden.

Hau, Peter, Apfel, Rainer, Wiese, Petra, Tschertner, Ines, Blesch, Armin und Bogdahn, Ulrich (2002) Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin. Anticancer research 22 (2A), S. 577-583. Volltext nicht vorhanden.

Fabel, K., Dietrich, J., Hau, Peter, Wismeth, C., Winner, B., Przywara, S., Steinbrecher, A., Ullrich, W. und Bogdahn, U. (2001) Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer 92 (7), S. 1936-1942. Volltext nicht vorhanden.

Diese Liste wurde erzeugt am Thu Mar 28 09:55:45 2024 CET.
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de
0941 943 -4239 oder -69394

Dissertationen: dissertationen@ur.de
0941 943 -3904

Forschungsdaten: datahub@ur.de
0941 943 -5707

Ansprechpartner